Indiva Announces Pre-Roll Partnership with the Supreme Cannabis Company, Inc.

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

Indiva to manufacture and distribute pre-rolls for Supreme Cannabis' portfolio of brands

LONDON, ON, Oct. 22, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (TSXV: NDVA) (OTCQX: NDVAF) is pleased to announce it has signed a definitive agreement with The Supreme Cannabis Company, Inc. ("Supreme Cannabis") (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) to manufacture and distribute pre-rolls for Supreme Cannabis' portfolio of brands from Indiva's facility in London, Ontario. The Supreme Cannabis portfolio includes recognized premium recreational and wellness brands like 7ACRES, Blissco and KKE.

"This partnership truly represents the best of Canada's cannabis industry. Together, Indiva and Supreme Cannabis will combine High End Cannabis™ with Indiva's signature handcrafted pre-rolls," Niel Marotta, Indiva's President and Chief Executive Officer, said. "We take a lot of pride in each and every pre-roll that we send to market and are pleased that our partners in the industry recognize the value of exceptional quality. Our commitment to consistency is shared by Supreme Cannabis and we are thrilled to support their passion for craftsmanship and dedication to growing better and in this case, together."

The agreement is for a one-year renewable term and is subject to minimum bi-weekly manufacturing volumes. The partnership is expected to initiate processing in late October. Indiva and Supreme Cannabis intend to work together to make product available across Canada.

Both INDIVA™ products and Supreme Cannabis' suite of brands are available online and in stores where cannabis is sold. Click here to learn more about Indiva and Supreme Cannabis.

ABOUT INDIVA
Indiva's global family of cannabis brands set the standard for quality and innovation. Indiva aims to bring its exceptional portfolio of products to Canadians and cannabis enthusiasts around the world as laws permit. Indiva's production facility, based in London, Ontario, includes aeroponic, environmentally-conscious grow rooms and a nearly completed extraction and manufacturing space, which will be able to process 70 tonnes of biomass annually and produce safe, high-quality cannabis-infused edibles. In Canada, Indiva will produce and distribute Ruby® Cannabis Sugar, Sapphire™ Cannabis Salt and Ruby® Gems, as well as the award-winning Bhang® Chocolate, and other derivative products through licence agreements and joint ventures. Click here to connect with Indiva on social media and here to find more information on the Company and its products.

DISCLAIMER AND READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the Company's future operations, future product offerings and entry into additional markets, changes to laws and regulations in Canada and internationally, and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary regulatory and other third parties' approvals and licensing and other risks associated with regulated entities in the cannabis industry. The forward-looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.

SOURCE Indiva Limited

MEDIA CONTACT : Kate Abernathy, Vice President of Communications, Phone: [phone], Email: [email protected]; INVESTOR CONTACT : Steve Low, Investor Relations, Phone: [phone], Email: [email protected]